Results 31 to 40 of about 45,158 (283)

Direct-acting oral anticoagulants in antiphospholipid syndrome

Научно-практическая ревматология, 2021
Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid ...
T. M. Reshetnyak, K. S. Nurbaeva
doaj   +1 more source

Clinical, Laboratory, and Therapeutic Analyses of 21 Patients with Neonatal Thrombosis and Antiphospholipid Antibodies: A Literature Review

Journal of Immunology Research, 2014
Objectives. A review of the literature reports neonatal thrombosis and antiphospholipid antibodies cases through a retrospective study that focuses on the pathogenesis and main clinical and laboratory manifestations of this disease. Methods.
Marcus Vinicius da Costa Peixoto, Jozélio Freire de Carvalho, Carlos Ewerton Maia Rodrigues   +2 more
doaj   +1 more source

Antiphospholipid Syndrome Associated with Systemic Lupus Erythematosus: A Case Report [PDF]

International Journal of Biomedicine
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by venous or arterial thrombosis and/or pregnancy outcomes in the presence of persistent antiphospholipid antibodies like lupus anticoagulant (LAC), anti-cardiolipin (aCL), and anti ...
Ina Toska, Ervin Rapushi, Rexhep Shkurti, Anila Mitre   +3 more
doaj   +1 more source

Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography [PDF]

, 2009
Lupus anticoagulants (LAC) consist of anti phospholipid antibodies, detected via their anti coagulant properties in vitro. Strong LAC relate to thromboembolic events, a hallmark of the anti-phospholipid syndrome.
arnout, jef, Devreese, Katrien, hoylaerts, marc, peerlinck, kathelijne   +3 more
core   +2 more sources

Review of presentations at the 6th European Lupus Meeting 3-5 March 2005. [PDF]

, 2005
The 6th European Lupus Meeting was held at the Royal College of Physicians of London and was attended by 450 delegates. The conference brought together leading speakers from Europe and North America who reviewed current knowledge and exciting new ...
Bowman, SJ, Giles, IP, Ioannou, Y, Rahman, A   +3 more
core   +1 more source

Prevalence of antiphospholipid antibodies in post-COVID and vaccinated individuals [PDF]

Infectious Diseases and Tropical Medicine
OBJECTIVE: The outbreak of COVID-19 resulted mainly in respiratory disease; however, apart from that, the infection was presented with random systemic thromboembolic events.
S. Al-Rustum, T. Kobulashvili, P. Sharma, S. Habeebulla, L. Bakhtadze   +4 more
doaj   +1 more source

Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis. [PDF]

, 2009
The aim of this study was to perform a meta-analysis of the association between the factor V Leiden polymorphism (FVL) and thrombosis among patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibody (aPL) positivity.
Barton, JL, Begovich, AB, Catanese, JJ, Chang, M, Criswell, LA, Kaiser, R, Li, Y   +6 more
core   +2 more sources

Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients

Journal of Immunology Research, 2022
Background. The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis. They could be a “second hit” of an inflammatory event such as infection.
Amal Abouda, Z. Hajjej, A. Mansart, W. Kaabechi, D. Elhaj Mahmoud, O. Lamine, E. Ghazouani, M. Ferjani, I. Labbene   +8 more
doaj   +1 more source

Diagnosis of antiphospholipid syndrome in routine clinical practice. [PDF]

, 2013
The updated international consensus criteria for definite antiphospholipid syndrome (APS) are useful for scientific clinical studies. However, there remains a need for diagnostic criteria for routine clinical use.
Cohen, H, Gardiner, C, Hills, J, Machin, SJ   +3 more
core   +1 more source

Antiphospholipid Syndrome: Changing Knowledge During the Time – The ”Four P” Pattern [PDF]

, 2012
The antiphospholipid syndrome has been described for the first time by Graham Hughes in 1983 as a condition connected with thromboses or foetal losses and antiphospholipid antibodies presence.
Buliková Alena
core   +2 more sources